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Our doubt: could a more incisive intervention for the protection of A.’s development
have the risk of a further invalidation of the mother, if the hypothesis about her
pathological psychological condition is correct?
Conclusion: After frequent attempts of creation of a better relationship with A.’s
parents we must evidence our failure: we did not ﬁnd the adequate way to manage
this case and we feel blocked between the comprehension of the mother’s difﬁculties
about her daughter’s illness and the hypothesis of Munchausen syndrome by Proxy,
or recognize the possibility of the mother’s psychiatric pathology.
She is currently separated from her husband and has refused the aid of a social
worker, eliminating any presence in the relationship between her and child. However
she continues to present an inadequate management of her daughter who has a
serious nutrition condition.
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When we speak of “communication of diagnosis” we usually mean the situation
in which the physician communicates to parents that their child is suffering
from cystic ﬁbrosis. Literature contains lot of articles facing this thematic from
the psychological point of view. Seldom has been considered the importance to
communicate and to give information to the child. Obviously during the ﬁrst years
of his life the child is not aware of illness, and he faces it through the emotions
of the adults. Therefore he is inﬂuenced by the feelings of his mother or other
important referee. When he becomes three-four years old he becomes aware of the
disease and, additionally, of his own body; he begins to be sensitive to the offered
explanations about the necessity of the visits, of the therapies or of the hospital
admissions and overall he needs to be informed about his performance status of
health avoiding to feel guilty for the disease and to feel therapies as maltreatments.
Beginning from this phase of development and even more afterward, too often are
parents to bear the responsibility to give answers and explanations to the children,
not always satisfactorily supported and helped by the health team of the Center. We
think, instead, it should be very important that physicians themselves must put up,
with the small patients, a good relationship characterized by unambiguous, sincere
and continual communication adapting it to the age of the child.
The communication of diagnosis is not a ﬁnishing event that reaches ends con-
clusions, but rather a never-ending situation that begins in the childhood and it
continues in the growing years.
If, meeting the child, we speak to him basically, explaining his disease and what
we are planning to do just to cure him and moreover we listen to his fears and we
answer his questions, only in this case we demonstrate respect to him as a human
being liberating him by a negative function of inactive object and beginning to build
a correct therapeutic strategy.
With this approach even a hard event, like a hospital admission, will not be
considered as a tragic experience to be removed but rather as an unavoidable
necessity without any alternative choice.
At last, the health staff should be aware of what kind of information about the
disease has been given to the patient by the parents, because a common strategy
should be planned together and implemented in concert. Resistances of the family
and the possible inclination to reject to speak to the child about illness should be
respected but as well discussed together.
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Introduction: The psychological, physical, and social impact of CF is complex and
varies among patients of different ages. In the last decade, health-related quality
of life (HRQoL), deﬁned as the "people subjective evaluation on the inﬂuences of
their current health status on the ability to achieve and maintain a level of overall
functioning" has become an essential outcome for chronic conditions.
This study is aimed at assessing HRQL in Italian CF patients cared for at the
Bambino Gesu` Children’s Hospital.
Patients and Methods: The inclusion criteria were: being regularly followed up,
7 years of age, ability to read Italian and absence of mental illness.
The age-speciﬁc versions of the Cystic Fibrosis Questionnaire (CFQ; Henry et
al, 1996) were used with permission. They were translated into Italian, and back-
translated into the original language (French) to check for semantic equivalence.
Higher scores indicate better quality of life.
Results: Out of 121 eligible patients, 118 accepted to participate (97.5%). Forty-
eight (40.7%) were aged 7−13 years; 27 (22.9%) were 14−17 years old, and 43
were 18 years or more (36.4%). Fifty-one percent were females.
Patients consistently reported scores higher than 70 on most of the domains.
Lower scores were obtained in “Treatment Constraints” and “Social Limitations”
sub-scales. Compared with older patients, younger ones had higher scores on
“Energy/wellbeing”, and lower on “Social Limitations”, “Eating Disturbances” and
“Digestive Symptoms”.
As expected, patients with the most compromised lung functioning (FEV1 <65)
showed lower HRQL scores, particularly in “Emotional functioning”, “Body im-
age”, “Treatment constraints” and “Respiratory symptoms”. No gender-related
differences were found.
Conclusions: HRQoL domain of “Social limitations” appears of most concern in
children and adolescents affected by CF, as “Treatment constraints” in patients with
compromised lung function.
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SFHR (Small Fragment Homologous Replacement) is a gene targeting strategy
based on homologous recombination (HR) of small DNA fragments (SDFs) into
the genomic DNA of recipient cells. The SFHR technique has also been applied
to modify the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR)
gene. The inadequate knowledge of the mechanisms of action of the SFHR limits
its reproducibility and efﬁciency. The relevance of SFHR for the correction of
CFTR defects, together with the still unexplored possibility of an inﬂuence on HR
of epigenetic DNA modiﬁcations, prompted us to investigate the effect of SDF
methylation on SFHR-mediated gene repair process efﬁciency.
We used our previously constructed assay system obtained by stable integration of
a mutated copy of enhanced green ﬂuorescent protein (EGFP) gene in immortalized
embryonic ﬁbroblasts DNA.
The SFHR efﬁciency was quantiﬁed by FACS analysis as the percentage of EGFP-
positive cells after correction. The effect of methylation status of the corrective frag-
ment was tested by comparison between PCR-ampliﬁed and plasmid-excised SDFs.
The presence of methylation on SDF was checked by digestion with methylation-
sensitive restriction enzymes, followed by PCR ampliﬁcation: the presence or ab-
sence of a PCR amplicon indicates, respectively, a methylated or unmethylated SDF.
In plasmid-excised SDF, we evidenced both DAM and DCM, but not HpaII,
methylation. No methylation was evidenced on PCR-ampliﬁed SDF. When a PCR-
ampliﬁed (unmethylated) SDF was transfected in cells synchronized in G2 phase,
the efﬁciency of correction was 0.1%. After transfecting a plasmid-excised (methy-
lated) SDF, a 15-fold increase of ﬂuorescent cells was evidenced, reaching 1.5%
of correction. Also the effect of speciﬁc methylation patterns, created on the SDF
fragment by treatment with speciﬁc methylases, was evaluated and will be discussed.
The 12% of residual CFTR functionality is usually accepted as the lower threshold
to be overcome to restore a normal phenotype in Cystic Fibrosis patients: the en-
hancement of SFHR efﬁciency due to SDF methylation opens up a new perspective
for the correction of mutated CFTR.
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Pseudomonas aeruginosa infection and chronic inﬂammation are hallmarks of lung
disease in cystic ﬁbrosis (CF).
Extracellular GSH is a scavenger of free radicals produced by neutrophils in
inﬂamed tissues.
Glutathione transferases (GST) are a superfamily of dimeric proteins which conju-
gate glutathione to a wide range of substrates including oxidants and are involved
the synthesis of leukotriens.
Azithromycin (AZM) ameliorates lung function in cystic ﬁbrosis (CF) patients. This
macrolide has been suggested to have anti-inﬂammatory properties as well as other
effects potentially relevant for therapy of CF.
The present investigation was aimed to verify the effects of AZM on GST activity
in CF cell lines.
